- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy ; volume:8 ; number:1 ; day:05 ; month:7 ; year:2007 ; pages:1-9 ; date:12.2007
BMC medical genetics ; 8, Heft 1 (05.7.2007), 1-9, 12.2007
- Creator
-
Aartsma-Rus, Annemieke
- Contributor
-
Janson, Anneke AM
van Ommen, Gert-Jan B.
van Deutekom, Judith CT
SpringerLink (Online service)
- DOI
-
10.1186/1471-2350-8-43
- URN
-
urn:nbn:de:1111-2016021833441
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aartsma-Rus, Annemieke
- Janson, Anneke AM
- van Ommen, Gert-Jan B.
- van Deutekom, Judith CT
- SpringerLink (Online service)
Other Objects (12)
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
Applying Lessons Learned from Developing Exon Skipping for Duchenne to Developing Individualized Exon Skipping Therapy for Patients with Neurodegenerative Diseases
Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis
Exon skipping for DMD
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
The dilemma of choice for duchenne patients eligible for Exon 51 skipping the European experience
Accelerated exon evolution within primate segmental duplications
The Assembly and Evaluation of Antisense Oligonucleotides Applied in Exon Skipping for Titin-based Mutations in Dilated Cardiomyopathy
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
Applying Lessons Learned from Developing Exon Skipping for Duchenne to Developing Individualized Exon Skipping Therapy for Patients with Neurodegenerative Diseases
Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis
Exon skipping for DMD
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
The dilemma of choice for duchenne patients eligible for Exon 51 skipping the European experience
Accelerated exon evolution within primate segmental duplications
The Assembly and Evaluation of Antisense Oligonucleotides Applied in Exon Skipping for Titin-based Mutations in Dilated Cardiomyopathy
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
Applying Lessons Learned from Developing Exon Skipping for Duchenne to Developing Individualized Exon Skipping Therapy for Patients with Neurodegenerative Diseases
Antisense‐mediated exon skipping: a therapeutic strategy for titin‐based dilated cardiomyopathy
Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis
Exon skipping for DMD
Adenine base editing-mediated exon skipping restores dystrophin in humanized Duchenne mouse model
Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
Assessment of the feasibility of exon 45–55 multiexon skipping for duchenne muscular dystrophy
Antisense Oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa
The dilemma of choice for duchenne patients eligible for Exon 51 skipping the European experience
Accelerated exon evolution within primate segmental duplications